- Research
- Open access
- Published:
Strong association between atherogenic index of plasma and obesity in college students
BMC Endocrine Disorders volume 25, Article number: 80 (2025)
Abstract
Background
The issue of obesity is becoming more and more prominent. Understanding the metabolic profile of obese young adults and finding possible risk markers for early prediction and intervention is of great importance.
Methods
A total of 13,082 college students with an average age of 20 years were enrolled in this cross-sectional study. The lipid composition was measured and novel lipid profiles such as AIP, AI, LCI, Non-HDL-C, TC/HDL-C, LDL-C/HDL-C and TyG were calculated. Participants were then assessed as normal weight, overweight or obese based on their BMI. Pearson correlation analysis, multivariate logistic analysis, and predictive analysis were used to assess the association and discriminative power between lipid profile and obesity.
Results
The prevalence of obesity with dyslipidemia was 61.0% in males and 38.7% in females. Most obese patients were associated with only one dyslipidemia component, with the highest proportion having low HDL-C. We found a positive correlation between all lipid profiles except HDL-C and BMI. Multivariate logistics regression shows, AIP were strongly associated with obesity, which shows the largest OR = 12.86, 95%CI (9.46,17.48).
Conclusions
In the youth population, higher AIP levels were positively and strongly associated with obesity. AIP may be a novel and better risk biomarker for predicting obesity.
Background
Obesity is a systemic disease characterized by excessive and abnormal accumulation of adipose tissue in the body [1]. Nowadays, the number of obese people is as high as 700 million, and it shows a rapid growth trend, which brings a huge economic burden to society [2]. The prevalence of overweight and obesity is peaking at younger ages [3]. According to estimates, 1% rate of overweight and obesity rates reduce among 16- to 17-year-olds, there would be 52,821 fewer obese people in the future and an average of $586 million less in health care costs after age 40 [4]. Therefore, understanding the metabolic signatures of obesity in youth and finding risk markers for early identification and intervention is of great social value.
Previous studies have shown that abnormal changes in blood lipids are heavily associated with the occurrence of obesity [5], which is also commonly observed in children or adolescents [6, 7]. It was previously suggested that lipid metabolism disorders are more prevalent in obese children and adolescents. Additional evidence has been demonstrated that children and adolescents with severe lipid metabolism disorders are at elevated risk for obesity and early atherosclerosis [8, 9]. Several studies suggested that abnormalities in the metabolism of individual lipid components or variations in some non-traditional significant lipid features, or changes in the joint ratio of lipid components, or in lipid-related derived indices, are strongly correlated with obesity in children and adolescents. For example, triglyceride/high-density lipoprotein cholesterol (TG/HDL-C), triglyceride glucose (TyG), visceral adiposity index (VAI) and height-corrected lipid accumulation product (HLAP) and atherogenic index of plasma (AIP) can be a useful predictor of obese adolescents [10,11,12,13,14].
Although known associations between excess weight and abnormal lipid concentrations have been concluded, it is worth paying close attention and considering that blood lipids are modified over time. Consideration of lipid profiles may provide a basis for assessing risk and monitoring the development of obesity and atherosclerosis, but additional evidence on the metabolic signatures of obesity in adolescents is still needed. Moreover, there is a temporal trend in lipid disorders over time [15] and previous study has shown that changes in blood lipids in youthful people have their own characteristics [16]. We therefore conducted this study to further elucidate the characteristics of abnormal lipid metabolism in obese young college students and to seek risk markers for early identification of obesity.
Methods
A total of 13,082 college students from Xinjiang Medical University were included in this study from 2018 to 2021. According to China’s diagnostic criteria for obesity, individuals with a body mass index (BMI) ranging from 24 to 27.9 are classified as having overweight, while those with a BMI of 28 or higher are categorized as obese [12]. Ultimately, 8,366 subjects were classified as normal weight, 3340 as having overweight, and 1,376 as obese. This study received approval and support from the Ethics Review Committee of the First Affiliated Hospital of Xinjiang Medical University. As the research was retrospective and based on real-world situations, obtaining informed consent from the students was not required. The study adheres to the ethical principles outlined in the 1975 Declaration of Helsinki.
After fasting for one night, relevant indicators were measured and recorded by a trained professional. Weight (kg) and height (m) were assessed with participants barefoot and wearing light clothing. Body Mass Index (BMI) was calculated by dividing weight by the square of height (kg/m²). Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured in a calm state following a period of rest. Venous blood samples were collected and stored in tubes under low temperature and anticoagulant conditions, with biochemical tests performed within 24 h. The results for Total Cholesterol (TC), Triglyceride (TG), High-Density Lipoprotein Cholesterol (HDL-C), Low-Density Lipoprotein Cholesterol (LDL-C), and other lipid indices were obtained using equipment for chemical analysis (Dimension AR/AVL Clinical Chemistry System, Newark, NJ, USA). All laboratory examinations were conducted at the Laboratory Center of the First Affiliated Hospital of Xinjiang Medical University.
Computational formula
The novel lipid parameters were calculated as follows:
Non-HDL-C = TC - HDL-C.
arteriosclerosis index(AI)= (TC-HDL)/HDL.
Atherogenic index of plasma (AIP) = lg (TG/HDL-C).
Lipoprotein combine index (LCI) = TC × TG × LDL-C/HDL-C.
Triglyceride glucose index(TyG) = Ln(TG*FBG/2).
Statistic
The data were analyzed using SPSS 26.0 for Windows statistical software (SPSS Inc., Chicago, IL, USA) and R (version 4.0.3). Categorical variables were expressed as numbers and percentages, while continuous variables were presented as means (SD) or medians (IQR). Student’s t-test or Mann-Whitney U-test was used to compare normally distributed numeric variables or nonnormally distributed continuous variables, respectively. BMI, AIP, and various lipid components (such as HDL-C, TC, TG, LDL-C) were assessed using the Pearson coefficient. Multivariate logistic regression analyses were conducted to examine the association between AIP, conventional lipid composition, and obesity. The area under the curve (AUC) value of the receiver operating characteristic (ROC) curve was calculated to compare the predictive value of AIP and three lipid components (TC, TG, LDL-C) in relation to obesity. All statistical tests were two-tailed with significance set at p < 0.05.
Results
13,082 young people took part in our study. Of those studied, 8,366 were of normal weight, 3,340 were overweight and 1,376 were obese. Table 1 shows the laboratory data of the three groups. Compared to the normal-weight group, subjects with excess weight had higher SBP, DBP, white blood cell(WBC), fasting blood glucose (FBG), hemoglobin(Hb), platelet(PLT), creatinine (Cr), alanine transaminase (ALT), aspartate transaminase (AST) and higher rate of dyslipidemia. The values of LDL-C, TG, TC, AIP, Non-HDL-C, TC/HDL-C, LDL-C/HDL-C, AI, LCI, TyG and TG/HDL-C were also higher in excess weight (Ps < 0.001). However, there were no significant differences in age and blood urea nitrogen (BUN) between normal weight and excess weight.
In Table 2, distribution of dyslipidemia in different genders were shown. The prevalence of obesity with dyslipidemia was 61.0% in men and 38.7% in women. Most obese patients were associated with only one dyslipidemia component, and the proportion of LHDL-C was the highest. More dyslipidemia was incidence in obesity compared to normal weight. To be specific, higher rates of HTC, HTG, HLDL-C and LHDL-C in total and male subjects with obesity. Only elevated rates of HTG and LHDL-C difference exist in females.
Figure 1 shows the significant correlation between clinical variables, lipid profiles (including HDL-C, LCI, TG, AIP, LDL-C/HDL-C, AI, TC/HDL-C, LDL-C, TC and Non-HDL-C) and BMI in all subjects. ALL lipid components and novel lipid variables beside HDL-C showed weak positive correlations with BMI (Ps < 0.01). HDL-C was negatively associated with BMI (r=-0.227, p < 0.01). SBP, DBP, WBC, AST and ALT also showed weak positive correlations with BMI (Ps < 0.01).
Table 3 shows the area under the ROC curve of each lipid index for obesity. In the overall subjects, the area under the curve of AIP, TC/HDL-C, LDL-C/HDL-C, AI, LCI and TG/HDL-C were all greater than 0.7 (AIP: 0.708, 95%CI (0.692,0.724), p < 0.001.
In Table 4, multivariate logistic regression was conducted to clarify the relationship between the lipid variables and obese. After adjusting for sex, age, SBP, WBC, ALT, AST, TBIL, FBG and Cr, AIP were firmly associated with obesity, OR = 12.86, 95%CI (9.46,17.48). In subgroup analysis, after adjusting for age, SBP, WBC, ALT, AST, TBIL, FBG and Cr, AIP showed significant stronger predictive power for obesity in males, OR = 29, 95%CI (19.65,42.8),P < 0.001; in female, OR = 2.09, 95%CI (1.19,3.69), P = 0.011.
Discussion
In this study, we examined the prevalence of dyslipidemia and obesity, and the association between obesity and dyslipidemia in a large sample of Chinese adults in their 20s. It was additionally suggested that increases in AIP were most strongly associated with elevated rates of obesity and that AIP may be an independent risk factor for obesity. In view of the trend of obesity and overweight at a younger age, we thought it would be useful to evaluate the ability of AIP to predict overweight and obesity in adolescents in order to predict obesity earlier. Early detection of blood lipid indicators and attention to dyslipidemia may capture the risk of future obesity early.
Obesity is a major public health problem of the 21st century. Studies show that BMI in children and adolescents has been on the rise for the past 40 years [17]. Studies have estimated that 398,000 children aged 6–9 years in 21 European countries are severely obese [18]. As a result, rising obesity rates have attracted increasing attention. The close relationship between obesity and blood lipids has been gradually recognized in recent years. Atherogenic index of plasma (AIP), as a fresh lipid index, is suggested to be a significant predictor of cardiovascular risk and widely recommended as a potential biomarker of atherosclerosis and cardiovascular disease (CVD) [19,20,21,22]. For example, Karadağ MK et al. proposed that the area under the curve of AIP was 0.66, and the sensitivity of AIP in diagnosing heart failure was 68% when the critical value was 0.47 [19]. In addition, numerous studies have demonstrated that AIP can be used as a marker for screening for subclinical atherosclerosis [20, 21] Moreover, Khosravi A et al. proposed in their study that when the critical point level was 0.62, the sensitivity of AIP to the diagnosis of unstable plaques in coronary artery disease (CAD) diseases was close to 90% [22]. Not incidentally, it has also shown a great ability to predict obesity in recent studies. Shen et al. found AIP is closely related to abdominal obesity and the detection rate of abdominal obesity increased as the AIP quartile increased [23]. Zhang et al. also found that AIP was significantly associated with obesity [24]. Zhu et al. also suggested that using AIP instead of HDL-C and TG significantly improved the risk prediction of obesity (AUC improvement = 0.011, P = 0.011) [25].
While AIP, as a composite indicator combining TG and HDL-C, it is reasonable to suspect that it is more closely related to obesity. Increasing evidence suggests that insulin resistance, the most common metabolic disorder in obesity, is the most significant driving force for obesity-related metabolic dyslipidemia [26]. In the physiological state, insulin promotes the hydrolysis of TG in very low density lipoprotein(VLDL) particles driven by lipoprotein lipase (LPL) and promotes hepatic lipase (HL) activity. However, a state of insulin resistance leads to a slowing of the clearance of TG-rich lipoproteins in plasma, ultimately leading to hypertriglyceridemia [27]. In addition, insulin resistance leads to increased lipolysis and excessive release of free fatty acids. They will not only promote the synthesis of lipids in the liver, but also promote the formation of VLDL [28]. The result of increased secretion and decreased clearance of VLDL particles is hypertriglyceridemia [29]. In addition, obesity and insulin resistance accelerate the accumulation of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particles by TG through cholesteryl ester transfer proteins (CETP) [30]. At this time, the enrichment of HDL in TG and the increase in HL activity resulted in faster clearance of TG-rich HDL produced by CETP-mediated transfer. Finally, they are hydrolyzed by HL to form small dense LDL (sdLDL) and dysfunctional HDL particles, which further lead to reduced plasma HDL-C levels [31, 32].
Our results confirmed a strong relationship between AIP and obesity among young students. Not only that, the AIP test is much cheaper and the test procedure is very simple. Therefore, large-scale AIP screening can be carried out in community and primary hospitals to find people who are likely to have elevated BMI and trend to be obese.
Limitation
Nevertheless, some shortcomings in our study must be acknowledged. First, it is not known whether the subjects’ diet, lifestyle and other factors that affect blood lipid levels changed in the short term before the blood samples were collected. In addition, We have not been able to conduct continuous follow-up to understand whether the changes in blood lipids are directly related to BMI. Finally, this is a cross-sectional study, and further high-quality cohort studies are needed to determine whether AIP can truly predict the development of obesity.
Conclusion
Our study confirms that AIP is an independent risk factor of abnormal weight. It can indeed be used as a novel predictor of obesity and has the ability to predict people with high risk of overweight and obesity early.
Data availability
The datasets during the current study are available from the corresponding author on reasonable request.
Abbreviations
- AI:
-
Arteriosclerosis index
- AIP:
-
Atherogenic index of plasma
- ALT:
-
Alanine transaminase
- AST:
-
Aspartate transaminase
- BMI:
-
Body mass index
- BUN:
-
Blood urea nitrogen
- CETP:
-
Cholesteryl ester transfer protein
- Cr:
-
Creatinine
- DBP:
-
Diastolic blood pressure
- FBG:
-
Fasting blood glucose
- Hb:
-
Hemoglobin
- HDL-C:
-
High density lipoprotein cholesterol
- HDL:
-
High density lipoprotein
- HL:
-
Hepatic lipase
- HLAP:
-
Height-corrected lipid accumulation product
- LCI:
-
Lipoprotein combine index
- LDL-C:
-
Low density lipoprotein cholesterol
- LDL:
-
Low density lipoprotein
- Lp:
-
Lipoprotein
- LPL:
-
Lipoprotein lipase
- Plt:
-
Platelet
- SBP:
-
Systolic blood pressure
- sdLDL:
-
Small dense LDL
- TBIL:
-
Total bilirubin
- TC:
-
Total cholesterol
- TG:
-
Triglyceride
- TyG:
-
Triglyceride glucose
- VAI:
-
Visceral adiposity index
- VLDL:
-
Very low density lipoprotein
- WBC:
-
white blood cell
References
Caruso A, Gelsomino L, Panza S, Accattatis FM, Naimo GD, Barone I, Giordano C, Catalano S, Andò S. Leptin: a heavyweight player in obesity-related cancers. Biomolecules. 2023;13(7):1084. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/biom13071084. PMID: 37509120; PMCID: PMC10377641.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42.
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–81. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S0140-6736(14)60460-8
Wang LY, Denniston M, Lee S, Galuska D, Lowry R. Long-term health and economic impact of preventing and reducing overweight and obesity in adolescence. J Adolesc Health. 2010;46(5):467–73.
Tárraga Marcos ML, Panisello Royo JM, Carbayo Herencia JA, Rosich Domenech N, Alins Presas J, Tárraga López PJ. Effect on the lipid parameters of an intervention to reduce weight in overweight and obese patients. Clin Investig Arterioscler. 2017;29(3):103–10. English, Spanish. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.arteri.2017.01.002. Epub 2017 Mar 17. PMID: 28318619.
Bora K, Pathak MS, Borah P, Das D. Association of decreased high-density lipoprotein cholesterol (HDL-C) with obesity and risk estimates for decreased HDL-C attributable to obesity: preliminary findings from a hospital-based study in a city from Northeast India. J Prim Care Community Health. 2017;8(1):26–30. Epub 2016 Aug 20. PMID: 27531078; PMCID: PMC5932653.
Reese JA, Roman MJ, Deen JF, Ali T, Cole SA, Devereux RB, Fretts AM, Howard WJ, Lee ET, Malloy K, Umans JG, Zhang Y. Dyslipidemia in American Indian adolescents and young adults: strong heart family study. J Am Heart Assoc. 2024;13(6):e031741. Epub 2024 Mar 6. PMID: 38445515; PMCID: PMC11010025.
Jeon J, Lee S, Oh C. Age-specific risk factors for the prediction of obesity using a machine learning approach. Front Public Health. 2023;10:998782. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fpubh.2022.998782. PMID: 36733276; PMCID: PMC9887184.
Yin R, Wang X, Li K, Yu K, Yang L. Lipidomic profiling reveals distinct differences in plasma lipid composition in overweight or obese adolescent students. BMC Endocr Disord. 2021;21(1):201. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12902-021-00859-7. PMID: 34641844; PMCID: PMC8513241.
Ferraro F, Martín M, Verona J, Gilligan L, Verona MF, Botta E, Tetzlaff W, Lozano Chiappe E, Boero L, Brites F. Increased cholesteryl ester transfer protein and lipoprotein-associated phospholipase A2 activities in children and adolescents presenting high triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio. Indian J Pediatr. 2021;88(12):1180–6. Epub 2021 Jun 7. PMID: 34097230.
Martin M, Davico B, Verona MF, Tetzlaff WF, Lozano Chiappe E, Gilligan L, Jimenez G, Gomez Rosso L, Ballerini G, Boero L, Verona J, Brites F. Impaired HDL-associated enzymes and proteins in children and adolescents with weight disorders and their association with novel cardiometabolic indexes. Nutr Metab Cardiovasc Dis. 2023;33(12):2517–26. Epub 2023 Sep 9. PMID: 37793940.
Dağ H, İncirkuş F, Dikker O. Atherogenic index of plasma (AIP) and its association with fatty liver in obese adolescents. Child (Basel). 2023;10(4):641. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/children10040641. PMID: 37189890; PMCID: PMC10136544.
Hamed N, Soliman A, De Sanctis V, Shaat M, Alaaraj N, Ahmed S, Qusad M, Siddiq K, Alyafei F. Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6–12 years). Acta Biomed. 2022;93(5):e2022213. https://doiorg.publicaciones.saludcastillayleon.es/10.23750/abm.v93i5.12679. PMID: 36300244; PMCID: PMC9686177.
Sapunar J, Aguilar-Farías N, Navarro J, Araneda G, Chandía-Poblete D, Manríquez V, Brito R, Cerda Á. Alta prevalencia de dislipidemias y riesgo aterogénico en una población infanto-juvenil [High prevalence of dyslipidemia and high atherogenic index of plasma in children and adolescents]. Rev Med Chil. 2018;146(10):1112–22. Spanish. doi: 10.4067/S0034-98872018001001112. PMID: 30724974.
Zachariah JP, Shittu T, Wang Y. Lipid temporal trends in normal-weight youth. Am Heart J. 2021;231:68–72. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ahj.2020.10.050. Epub 2020 Oct 21. PMID: 33096104; PMCID: PMC7755735.
Liu LY, Aimaiti X, Zheng YY, Zhi XY, Wang ZL, Yin X, Pan Y, Wu TT, Xie X. Epidemic trends of dyslipidemia in young adults: a real-world study including more than 20,000 samples. Lipids Health Dis. 2023;22(1):108. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-023-01876-2. PMID: 37516842; PMCID: PMC10386655.
Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, et al. NCD risk factor collaboration (NCD-RisC) worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42.
B.Spinelli A, Buoncristiano M, Kovacs VA, Yngve A, Spiroski I, Obreja G, Starc G, Pérez N, Rito AI, Kunešová M, Sant’Angelo VF, Meisfjord J, Bergh IH, Kelleher C, Yardim N, Pudule I, Petrauskiene A, Duleva V, Sjöberg A, Gualtieri A, Hassapidou M, Hyska J, Burazeri G, Petrescu CH, Heinen M, Takacs H, Zamrazilová H, Bosi TB, Sacchini E, Pagkalos I, Cucu A, Nardone P, Gately P, Williams J, Breda J. Prevalence of severe obesity among primary school children in 21 European countries. Obes Facts. 2019;12(2):244–58. Epub 2019 Apr 26. PMID: 31030201; PMCID: PMC6547273.
Karadağ MK, Yıldırım E. Relationship of atherogenic index of plasma and mean platelet volume with ejection fraction in ischemic and nonischemic heart failure. Biomark Med. 2019;13(3):175–83.
Cure E, Icli A, Uslu AU, Sakiz D, Cure MC, Baykara RA, Yavuz F, Arslan S, Kucuk A. Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis: AIP associate with cIMT in AS. Clin Rheumatol. 2018;37(5):1273–80.
Won KB, Heo R, Park HB, Lee BK, Lin FY, Hadamitzky M, Kim YJ, Sung JM, Conte E, Andreini D, Pontone G, Budoff MJ, Gottlieb I, Chun EJ, Cademartiri F, Maffei E, Marques H, de Araújo Gonçalves P, Leipsic JA, Lee SE, Shin S, Choi JH, Virmani R, Samady H, Chinnaiyan K, Berman DS, Narula J, Shaw LJ, Bax JJ, Min JK, Chang HJ. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis. 2021;324:46–51.
Khosravi A, Sadeghi M, Farsani ES, Danesh M, Heshmat-Ghahdarijani K, Roohafza H, Safaei A. Atherogenic index of plasma: a valuable novel index to distinguish patients with unstable atherogenic plaques. J Res Med Sci. 2022;27:45.
Shen SW, Lu Y, Li F, Yang CJ, Feng YB, Li HW, Yao WF, Shen ZH. Atherogenic index of plasma is an effective index for estimating abdominal obesity. Lipids Health Dis. 2018;17(1):11. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-018-0656-1. PMID: 29334966; PMCID: PMC5769292.
Zhang JS, Yeh WC, Tsai YW, Chen JY. The relationship between atherogenic index of plasma and obesity among adults in Taiwan. Int J Environ Res Public Health. 2022;19(22):14864. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/ijerph192214864. PMID: 36429582; PMCID: PMC9691148.
Zhu X, Yu L, Zhou H, Ma Q, Zhou X, Lei T, Hu J, Xu W, Yi N, Lei S. Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China. Lipids Health Dis. 2018;17(1):37. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-018-0686-8. PMID: 29506577; PMCID: PMC5836428.
Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. Obesity and dyslipidemia. Metabolism. 2019;92:71–81. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.metabol.2018.11.005. Epub 2018 Nov 14. PMID: 30447223.
Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA. Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract. 2011;93 Suppl 1:S52-9. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S0168-8227(11)70014-6. PMID: 21864752.
Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.
Packard CJ, Boren J, Taskinen MR. Causes and consequences of hypertriglyceridemia. Front Endocrinol (Lausanne). 2020;11:252.
Zeljkovic A, Vekic J, Mihajlovic M, Gojkovic T, Vladimirov S, Zeljkovic D, et al. Revealing the role of high-density lipoprotein in colorectal cancer. Int J Mol Sci. 2021;22(7):3352. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/ijms22073352
Chatterjee C, Sparks DL. Hepatic lipase, high density lipoproteins, and hypertriglyceridemia. Am J Pathol. 2011;178(4):1429–33. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ajpath.2010.12.050
Stadler JT, Marsche G. Obesity-related changes in high-density lipoprotein metabolism and function. Int J Mol Sci. 2020;21(23):8985. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/ijms21238985
Acknowledgements
We thank all students for participating in this study. We are also grateful to the clinic of the Xinjiang Medical University.
Funding
This work was supported by the National Natural Science Foundation of China (82360097,82170345).
Author information
Authors and Affiliations
Contributions
WZL and JML made substantial contributions to study conception and design and to the drafting and critical revision of the manuscript for important intellectual content; SCH and XYZ collected data and undertook the statistical analyses; XY , YTL and YYZ gave critical comments on the draft and contributed to the manuscript writing; TTW and XX made substantial contributions to study conception and design, drafting and critical revision of the manuscript for important intellectual content, including study supervision. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
The research protocol was approved by the ethics committee or review committee of the First Affiliated Hospital of Xinjiang Medical University. The approval number is K202403-43. Because the study was a retrospective study based on real-world situations, there was no need to obtain informed consent from the students.
Consent for publication
Not Applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Wang, ZL., Li, J., Sun, CH. et al. Strong association between atherogenic index of plasma and obesity in college students. BMC Endocr Disord 25, 80 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12902-024-01807-x
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12902-024-01807-x